Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Head-to-head comparison of aripiprazole and risperidone in the treatment of ADHD symptoms in children with autistic spectrum disorder and ADHD: a pilot, open-label, randomized controlled study
10.1158/1078-0432.CCR-09-3191 Clin
Glucagon-like peptide 1 receptor agonist Zp10a increases insulin mRNA expression and prevents diabetic progression in Db/Db mice
As the body ages, natural levels of GHK-Cu decline, which contributes to thinning skin, loss of elasticity, slower regeneration, dullness, and more visible signs of aging
Here's the full picture: this @Stifel pipeline infographic shows all obesity drugs currently in clinical trials, organized by development stage and mechanism
In November and December 2025, the two largest clinical trials ever run with a glucagon-like peptide-1 receptor (GLP-1R) agonist in a neurodegenerative disease reported their results
US$ 25.17
US$ 28.66
US$ 24.68
US$ 28.74
US$ 26.45
